Kharaba Zelal, Moutraji Sedq A, Khawaldeh Rama A Al, Alfoteih Yassen, Meslamani Ahmad Z Al
Department of Clinical Sciences, AAU Health and Biomedical Research Center, College of Pharmacy, Al Ain University, Abu Dhabi, UAE.
Department of Clinical Sciences, College of Pharmacy, Al Ain University, Abu-Dhabi, UAE.
Pharm Pract (Granada). 2022 Apr-Jun;20(2):2656. doi: 10.18549/PharmPract.2022.2.2656. Epub 2022 Jun 1.
The study aimed to investigate the impact of Coronavirus disease (COVID-19) on the roles of hospital and community pharmacists in the United Arab Emirates (UAE) and to assess how COVID-19 has affected their roles concerning medication dispensing and review, patient education, and telepharmacy services.
This was a face-to-face questionnaire-based study. A convenient sampling technique was used to collect responses from 428 licensed community and hospital pharmacists across the UAE. The study tool is a structured questionnaire. Data were cleaned and analysed through SPSS Version 26.
In terms of medication dispensing practice, 314 (73.4%) and 210 (49.1%) of pharmacists reported an increase in the dispensing of over the counter (OTC) medicines and antibiotics after COVID-19, respectively. Of the pharmacists included in the study, 380 (88.8%) and 328 (76.6%) reported an elevation in the engagement in patient education and medication review after COVID-19, respectively. On the other hand, 247 (57.7%) and 179 (41.8%) of pharmacists reported that the frequency of their pharmaceutical interventions and physicians' acceptance of those interventions increased after COVID-19, which was significantly associated (p=0.01) with pharmacists' ability to intervene on the dosage regimen of COVID-19 patient.
Pharmaceutical care in the UAE has evolved after COVID-19, particularly in the aspects of medications dispensing, telepharmacy, and patient-centered services..
本研究旨在调查冠状病毒病（COVID-19）对阿拉伯联合酋长国（阿联酋）医院和社区药剂师角色的影响，并评估COVID-19如何影响他们在药品调配与审核、患者教育以及远程药学服务方面的角色。
这是一项基于面对面问卷调查的研究。采用便利抽样技术收集了阿联酋428名有执照的社区和医院药剂师的回复。研究工具是一份结构化问卷。数据通过SPSS 26版进行清理和分析。
在药品调配实践方面，分别有314名（73.4%）和210名（49.1%）药剂师报告称，COVID-19后非处方药（OTC）和抗生素的调配量有所增加。在参与研究的药剂师中，分别有380名（88.8%）和328名（76.6%）报告称，COVID-19后参与患者教育和药品审核的程度有所提高。另一方面，分别有247名（57.7%）和179名（41.8%）药剂师报告称，COVID-19后他们的药学干预频率以及医生对这些干预的接受度有所增加，这与药剂师对COVID-19患者用药方案进行干预的能力显著相关（p=0.01）。
COVID-19后阿联酋的药学服务有所发展，特别是在药品调配、远程药学和以患者为中心的服务方面。
